---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-022885"
form_type: "8-K"
ticker: null
cik: "0001769804"
company_name: "Augmedix, Inc."
filed_at: "2024-05-13T23:59:59+00:00"
generated_at: "2026-06-02T02:33:45.602040+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Augmedix Q1 revenue up 40% to $13.5M; guides FY24 lower on AI purchasing slowdown

## Summary
- Revenue $13.5M (+40% YoY); gross margin 47.1% (up 150 bps).
- Net loss $6.5M vs $5.2M; adjusted EBITDA loss $5.1M vs $4.3M.
- Dollar-based Net Revenue Retention 143% vs 136% for Health Enterprise.
- CEO cites slower purchasing commitments; full-year revenue outlook lowered.
- Cash $37.3M; HCA Healthcare planning expansion of Augmedix Go to more EDs.

## SEC filing metadata
- accession: 0001628280-24-022885
- form_type: 8-K
- cik: 0001769804
- company_name: Augmedix, Inc.
- filed_at: 2024-05-13T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1769804/000162828024022885/0001628280-24-022885-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1769804/000162828024022885/augx-20240513.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-022885
- JSON: https://secwatch.observer/filing/0001628280-24-022885.json
- Plain text: https://secwatch.observer/filing/0001628280-24-022885.txt

## Key facts
- Earnings Releases
  Augmedix, Inc. reported first quarter ended March 31, 2024 results: revenue $13,471, net income $(6,499), EPS $(0.12).
  - Period: first quarter ended March 31, 2024
  - Revenue: $13,471
  - Net income: $(6,499)
  - EPS: $(0.12)
  - Result: reported results
  source text: healthcare systems and clinicians who are helping us optimize our suite of solutions.” 1 Three Months Ended March 31, Financial Highlights: 2024 2023 Change Revenues $13,471 $9,628 40% Gross profit $6,341 $4,386 45% Gross margin 47.1 % 45.6 % 150 bps Net loss $(6,499) $(5,239) (24)% Loss per share $(0.12) $(0.14) 14% Adjusted EBITDA (non-GAAP)
  evidence_url: https://www.sec.gov/Archives/edgar/data/1769804/000162828024022885/0001628280-24-022885-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.